MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

Home > LMB In The News > Sortera Bio has raised £7.5m pre-seed investment from AstraZeneca, BioNTech and CIC

Sortera Bio has raised £7.5m pre-seed investment from AstraZeneca, BioNTech and CIC

Published on

Business Weekly reports that Sortera Bio, an LMB spinout company, has attracted backers for a £7.5m pre-seed round to power AI models for drug discovery. The round was led by Cambridge Innovation Capital (CIC) with participation from AstraZeneca and BioNTech. More…